EE03091B1 - Composition for stabilizing plasma by pasteurization, method for pasteurizing plasma and products obtained by this method for therapeutic use - Google Patents

Composition for stabilizing plasma by pasteurization, method for pasteurizing plasma and products obtained by this method for therapeutic use

Info

Publication number
EE03091B1
EE03091B1 EE9400005A EE9400005A EE03091B1 EE 03091 B1 EE03091 B1 EE 03091B1 EE 9400005 A EE9400005 A EE 9400005A EE 9400005 A EE9400005 A EE 9400005A EE 03091 B1 EE03091 B1 EE 03091B1
Authority
EE
Estonia
Prior art keywords
plasma
composition
therapeutic use
pasteurizing
pasteurization
Prior art date
Application number
EE9400005A
Other languages
Estonian (et)
Inventor
Burnouf Miryana
Original Assignee
Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord filed Critical Association pour l'Essor de la Transfusion Sanguine dans la R�gion du Nord
Publication of EE03091B1 publication Critical patent/EE03091B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a composition intended to stabilise blood plasma during pasteurisation, the blood plasma being whole or devoid of cryoproteins. The composition according to the invention makes it possible to pasteurise very large quantities of plasma (of the order of 60 litres). The invention also relates to the method for pasteurisation of the plasma using the stabilising composition. The pasteurised plasma obtained is intended for therapeutic use.
EE9400005A 1992-02-13 1994-05-23 Composition for stabilizing plasma by pasteurization, method for pasteurizing plasma and products obtained by this method for therapeutic use EE03091B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201604A FR2687317B1 (en) 1992-02-13 1992-02-13 COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION AND PASTEURIZED PLASMATIC SOLUTION FOR THERAPEUTIC USE.

Publications (1)

Publication Number Publication Date
EE03091B1 true EE03091B1 (en) 1998-06-15

Family

ID=9426597

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400005A EE03091B1 (en) 1992-02-13 1994-05-23 Composition for stabilizing plasma by pasteurization, method for pasteurizing plasma and products obtained by this method for therapeutic use

Country Status (20)

Country Link
EP (1) EP0556096B1 (en)
JP (2) JP4010573B2 (en)
AT (1) ATE171074T1 (en)
BR (1) BR9300524A (en)
CA (1) CA2089446C (en)
CZ (1) CZ285573B6 (en)
DE (1) DE69321007T2 (en)
DK (1) DK0556096T3 (en)
EE (1) EE03091B1 (en)
ES (1) ES2121065T3 (en)
FI (1) FI103380B (en)
FR (1) FR2687317B1 (en)
HU (1) HU210026B (en)
LT (1) LT3226B (en)
LV (1) LV10195B (en)
NO (1) NO306532B1 (en)
PL (1) PL174098B1 (en)
RU (1) RU2112522C1 (en)
SK (1) SK280665B6 (en)
UA (1) UA27102C2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501189D0 (en) * 1995-03-31 1995-03-31 Pharmacia Ab Protein formulation
US5616159A (en) * 1995-04-14 1997-04-01 Corning Incorporated Method of forming high purity fused silica having high resistance to optical damage
US6619073B2 (en) 1996-03-05 2003-09-16 Corning Incorporated Method of increasing the initial transmittance of optical glass
US5879875A (en) * 1996-06-14 1999-03-09 Biostore New Zealand Compositions and methods for the preservation of living tissues
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
US5962213A (en) * 1996-06-14 1999-10-05 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
EP1018866B1 (en) * 1996-06-14 2002-12-04 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
US6037116A (en) * 1996-06-14 2000-03-14 Biostore New Zealand, Ltd. Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials
US6114107A (en) * 1996-06-14 2000-09-05 Biostore New Zealand Limited Composition comprising raffinose, TMAO, sodium citrate and methods for the preservation of living tissues
US6361933B1 (en) 1996-06-14 2002-03-26 Biostore New Zealand Limited Solutions for the preservation of tissues
RU2174841C1 (en) * 2000-06-06 2001-10-20 Российский научно-исследовательский институт гематологии и трансфузиологии Method of normal plasma pool preparing
US6915665B2 (en) 2000-10-31 2005-07-12 Corning Incorporated Method of inducing transmission in optical lithography preforms
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
ES2264403B1 (en) * 2006-06-22 2007-11-01 Grifols S.A. HEMATIES SUSPENSION MEDIA.
DE102011056142A1 (en) * 2011-12-07 2013-06-13 Manfred Rüdinger Metabolizable salts and their use in diagnostics and therapy
RU2639446C1 (en) * 2016-11-23 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ярославский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for storage of blood plasma containing drugs with unstable phenolic hydroxiles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045153A1 (en) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg METHOD FOR THE PRODUCTION OF BLOOD COagulation FACTORS AND THE PREPARATION OF FACTORS IX AND X THEREFORE PRODUCED
DE3230849A1 (en) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg PASTEURIZED HUMAN FIBRINOGEN (HF) AND METHOD FOR THE PRODUCTION THEREOF
DE3237512A1 (en) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg METHOD FOR PASTEURIZING ANTIHAEMOPHILIC CRYOPRAEZIPITATE (AHK) AND ANTIHAEMOPHILE CRYOPRAECIPITATE PRODUCED THEREOF
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (en) * 1983-01-20 1984-08-02 Green Cross Corp:The Heat treatment of viii factor of blood clotting
DE3330770A1 (en) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg METHOD FOR PASTEURIZING HUMAN PLASMA
FR2650508A1 (en) * 1989-08-01 1991-02-08 Fondation Nale Transfusion San PASTEURIZED ADHESIVE FOR JOINING HUMAN OR ANIMAL TISSUES
FR2664165B1 (en) 1990-07-03 1992-10-16 Lille Transfusion Sanguine COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION.

Also Published As

Publication number Publication date
CA2089446C (en) 2006-04-18
JP4010573B2 (en) 2007-11-21
HU210026B (en) 1995-01-30
PL174098B1 (en) 1998-06-30
LV10195A (en) 1994-10-20
EP0556096B1 (en) 1998-09-16
FI930630L (en) 1993-08-14
DK0556096T3 (en) 1999-06-14
DE69321007D1 (en) 1998-10-22
SK8293A3 (en) 1993-10-06
JP4472672B2 (en) 2010-06-02
NO930473D0 (en) 1993-02-11
FI103380B1 (en) 1999-06-30
LTIP338A (en) 1994-08-25
RU2112522C1 (en) 1998-06-10
NO930473L (en) 1993-08-16
LV10195B (en) 1995-04-20
ES2121065T3 (en) 1998-11-16
HUT63768A (en) 1993-10-28
EP0556096A1 (en) 1993-08-18
FR2687317B1 (en) 1995-06-23
JPH0624997A (en) 1994-02-01
CA2089446A1 (en) 1993-08-14
ATE171074T1 (en) 1998-10-15
JP2006306892A (en) 2006-11-09
NO306532B1 (en) 1999-11-22
CZ16193A3 (en) 1993-12-15
DE69321007T2 (en) 1999-04-01
FI103380B (en) 1999-06-30
FR2687317A1 (en) 1993-08-20
UA27102C2 (en) 2000-02-28
LT3226B (en) 1995-04-25
FI930630A0 (en) 1993-02-12
CZ285573B6 (en) 1999-09-15
BR9300524A (en) 1993-09-28
SK280665B6 (en) 2000-05-16
PL297699A1 (en) 1994-01-10
HU9300377D0 (en) 1993-04-28

Similar Documents

Publication Publication Date Title
EE03091B1 (en) Composition for stabilizing plasma by pasteurization, method for pasteurizing plasma and products obtained by this method for therapeutic use
ES2016336B3 (en) BEVERAGES OF FRUIT JUICES AND CONCENTRATES OF JUICES NUTRITIONALLY SUPPLIED WITH CALCIUM.
AU2899789A (en) Low fat spread
RU93004727A (en) COMPOSITION FOR STABILIZING BLOOD PLASMA, METHOD FOR PASTERIZING PLASMA AND USING STABILIZED PLASMA IN THERAPY
DK0590172T3 (en) Refrigerated, pasteurized, spreadable meat or fish mousse and process for its preparation.
FR2664165B1 (en) COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION.
ATE129128T1 (en) EMULSIFIED FLAVOR MODIFYING COMPOSITION.
SE8404774L (en) PROCEDURE FOR CONTINUOUS TREATMENT OF NATURAL BODY BY STERILIZATION

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110523